In 2021, Damen et al. performed a randomized, double-blind, placebo-controlled, cross-over study on the effects of oxytocin versus the placebo treatment for three months in children with PWS to investigate changes in social behaviors and hyperphagia, with differences between males and females and between PWS molecular genetic classes. The gene discussed is OXT; the disease is Prader-Willi syndrome.